Cite Filings / RYTM / 0000102909-26-002111

Feed Companies Filings Check

Sign in

SCHEDULE 13G/A

Statement of Beneficial Ownership

RHYTHM PHARMACEUTICALS, INC. Filed 2026-03-27 Acc 0000102909-26-002111

Documents 1

SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X02/primary_doc.xml

Around this filing

2026-05-15 SCHEDULE 13G/A Statement of Beneficial Ownership
2026-04-03 4 EVP, Head of International acquired 12,875 shares (option exercise)
2026-04-03 4 Options or other derivatives
2026-03-27 SCHEDULE 13G/A Statement of Beneficial Ownership
2026-03-26 8-K Regulation FD disclosure · Other events
2026-03-20 8-K Regulation FD disclosure · Other events
2026-02-17 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X02/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…